ibudilast has been researched along with Glioblastoma in 2 studies
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alban, TJ | 1 |
| Bayik, D | 1 |
| Otvos, B | 1 |
| Rabljenovic, A | 1 |
| Leng, L | 1 |
| Jia-Shiun, L | 1 |
| Roversi, G | 1 |
| Lauko, A | 1 |
| Momin, AA | 1 |
| Mohammadi, AM | 1 |
| Peereboom, DM | 1 |
| Ahluwalia, MS | 1 |
| Matsuda, K | 2 |
| Yun, K | 1 |
| Bucala, R | 1 |
| Vogelbaum, MA | 1 |
| Lathia, JD | 1 |
| Ha, W | 1 |
| Sevim-Nalkiran, H | 1 |
| Zaman, AM | 1 |
| Khasraw, M | 1 |
| Nowak, AK | 1 |
| Chung, L | 1 |
| Baxter, RC | 1 |
| McDonald, KL | 1 |
2 other studies available for ibudilast and Glioblastoma
| Article | Year |
|---|---|
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
Topics: Animals; Brain Neoplasms; Glioblastoma; Humans; Immunotherapy; Macrophage Migration-Inhibitory Facto | 2020 |
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF).
Topics: Aged; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; DNA Methylation; DNA Modifi | 2019 |